Treatment of gum defects using hyaluronic acid and polynucleotides
Official title: Characterizing the Healing of Periodontal Supra-bony Defects Treated With Hyaluronic Acid and Polynucleotides
Run by Queen Mary University of London · NCT06309719 · Data updated 2026-11-12
This study is testing if adding a special gel to gum surgery helps people with gum disease heal better and faster.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | Queen Mary University of London Academic / other |
| Locations | 2 sites (London and 1 other locations) |
| Status | Recruiting |
| Started | October 21, 2024 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | July 2, 2026 |
| Trial ID | NCT06309719 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are systemically healthy adults aged 18 and older with stage III or IV periodontitis and supra-bony defects.
✕Probably not a fit
Patients with less severe periodontal conditions or those who have not completed prior non-surgical periodontal treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to investigate the early molecular events in wound healing and the vascularization patterns associated with treating supra-bony defects in periodontitis patients. Participants will undergo a parallel-group intervention involving either a periodontal access flap alone or in combination with a gel formulation of hyaluronic acid and polydeoxyribonucleotides. The study will involve up to 24 patients over a minimum period of 4 months, with a total of 7 visits to assess the outcomes. The research is being conducted at the Centre for Oral Clinical Research at Queen Mary University of London.
Why it matters
Potential benefit: If successful, this treatment could enhance healing and improve outcomes for patients with periodontal diseases.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in enhancing periodontal healing, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Systemically healthy males and females ≥18 years old * Stage III or IV periodontitis (Papapanou, Sanz et al. 2018) * Presence of supra-bony periodontal defects (i.e., defects where the base of the pocket is located coronal to the alveolar crest and characterized by a predominantly horizontal pattern of tissue destruction) confirmed clinically and radiographically at a minimum of two and a maximum of four adjacent teeth and with a probing pocket depth (PPD) \> 5 mm, following non-surgical periodontal therapy (NSPT). If \>4 adjacent teeth exhibited the above clinical and radiographic conditions, the four adjacent teeth showing the greatest overall loss of periodontal attachment were included. Wisdom teeth and second molars will not be considered for the study. If defect presents with an intrabony component, this should be ≤2 mm. * Non-surgical periodontal treatment (step 1 and 2) completed within the previous 4 months * Full-mouth bleeding score (FMBS) and full-mouth plaque score (FMPS) ≤20% Exclusion Criteria: * Teeth with degree III mobility * Multi-rooted teeth with grade ≥2 furcation involvement * Heavy smokers (≥10 cigarettes a day) * Untreated caries or endodontic lesions or abscesses on the teeth involved in the surgery * Previous periodontal surgery in the area selected for the study * History of conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures (e.g., mitral valve prolapse, artificial heart) * Antibiotic or anticoagulant therapy during the month preceding the baseline exam. * History of alcohol or drug abuse * Medical history that includes uncontrolled diabetes or hepatic or renal diseases, or other serious medical conditions that can have a negative impact on the periodontal condition * In treatment with medications that can severely affect bone metabolism and blood clot formation (e.g., anticoagulants, long-term corticosteroids, bisphosphonates, immunosuppressants) * Self-reported pregnancy or lactation.
Where it's running
-
Barts Health NHS Trust Dental Hospital
London, United Kingdom Recruiting -
Centre for Oral Clinical Research (COCR)
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Elena Calciolari, DDS, MS, PhD — Qmul
- Study coordinator: Miljana Bacevic
- Email: BHNT.Clinicaloralresearchcentre@nhs.net
- Phone: +442078823063
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyaluronic acid and octenidine gel with non-surgical gum treatment
This pilot will test whether adding a hyaluronic acid and octenidine gel to non-surgical periodontal treatment helps adults with advanced periodontitis heal faster and reduce inflammation.
-
JAK1 and JAK2 activation in healthy versus inflamed gums
We will test whether the JAK1 and JAK2 immune-signaling pathways are more active in adults with periodontitis than in adults with healthy gums.
-
Platelet-rich fibrin added to deep tooth cleaning for periodontitis
This will try adding platelet-rich fibrin (PRF) to deep non-surgical cleaning to see if it improves gum healing and attachment in adults with stage II–IV periodontitis.
-
Comparing three types of papilla incision techniques in periodontal surgery
This study is testing three different ways to make cuts in the gums during periodontal surgery to see which method works best for treating gum disease.
-
Comparing two surgical methods for treating periodontitis
This study tests which of two surgical methods works better for people with periodontitis who still have deep pockets around their teeth after initial treatment.
-
Biologic agents added to non-surgical periodontal therapy for intrabony defects
This study tests whether adding rhPDGF, L-PRF, or enamel matrix derivatives to minimally invasive non-surgical therapy helps restore deep bone defects in periodontitis patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.